Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study
Tao Huang, Sheng Zhang, De-Fang Dai, Busen Wang, Lu Zhuang, Hai-Tao Huang, Zhongfang Wang, Jun-Shi Zhao, Qiuping Li, Shipo Wu, Xue Wang, Wen-Dan Zhang, Zhenghao Zhao, Hao Li, Yan-Ping Zhang, Xiu-Liang Yang, Xin-Yang Jiang, Jin-Bo Gou, Lihua Hou, Lidong Gao, Zhichun Feng
Topics & Concepts
MedicineBooster doseImmunogenicityBooster (rocketry)VaccinationAdverse effectHeterologousHerd immunityPopulationInactivated vaccineImmunologyPediatricsVirologyInternal medicineImmunizationAntibodyEnvironmental healthAstronomyChemistryGeneBiochemistryPhysicsSARS-CoV-2 and COVID-19 ResearchVirology and Viral DiseasesVaccine Coverage and Hesitancy